Cargando…
Bovine adenovirus-3 as a vaccine delivery vehicle
The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conve...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115382/ https://www.ncbi.nlm.nih.gov/pubmed/25498212 http://dx.doi.org/10.1016/j.vaccine.2014.11.055 |
_version_ | 1783514085230379008 |
---|---|
author | Ayalew, Lisanework E. Kumar, Pankaj Gaba, Amit Makadiya, Niraj Tikoo, Suresh K. |
author_facet | Ayalew, Lisanework E. Kumar, Pankaj Gaba, Amit Makadiya, Niraj Tikoo, Suresh K. |
author_sort | Ayalew, Lisanework E. |
collection | PubMed |
description | The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conventional means are imperfect in many respects including virulence, safety and efficacy. Moreover, there are no vaccines for some animal diseases. Although genetic engineering has provided new ways of producing effective vaccines, the cost of production for veterinary use is a critical criterion for selecting the method of production and delivery of vaccines. The cost effective production and intrinsic ability to enter cells has made adenovirus vectors a highly efficient tool for delivery of vaccine antigens. Moreover, adenoviruses induce both humoral and cellular immune responses to expressed vaccine antigens. Since nonhuman adenoviruses are species specific, the development of animal specific adenoviruses as vaccine delivery vectors is being evaluated. This review summarizes the work related to the development of bovine adenovirus-3 as a vaccine delivery vehicle in animals, particularly cattle. |
format | Online Article Text |
id | pubmed-7115382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71153822020-04-02 Bovine adenovirus-3 as a vaccine delivery vehicle Ayalew, Lisanework E. Kumar, Pankaj Gaba, Amit Makadiya, Niraj Tikoo, Suresh K. Vaccine Article The use of vaccines is an effective and relatively inexpensive means of controlling infectious diseases, which cause heavy economic losses to the livestock industry through animal loss, decreased productivity, treatment expenses and decreased carcass quality. However, some vaccines produced by conventional means are imperfect in many respects including virulence, safety and efficacy. Moreover, there are no vaccines for some animal diseases. Although genetic engineering has provided new ways of producing effective vaccines, the cost of production for veterinary use is a critical criterion for selecting the method of production and delivery of vaccines. The cost effective production and intrinsic ability to enter cells has made adenovirus vectors a highly efficient tool for delivery of vaccine antigens. Moreover, adenoviruses induce both humoral and cellular immune responses to expressed vaccine antigens. Since nonhuman adenoviruses are species specific, the development of animal specific adenoviruses as vaccine delivery vectors is being evaluated. This review summarizes the work related to the development of bovine adenovirus-3 as a vaccine delivery vehicle in animals, particularly cattle. Elsevier Ltd. 2015-01-15 2014-12-09 /pmc/articles/PMC7115382/ /pubmed/25498212 http://dx.doi.org/10.1016/j.vaccine.2014.11.055 Text en Copyright © 2014 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ayalew, Lisanework E. Kumar, Pankaj Gaba, Amit Makadiya, Niraj Tikoo, Suresh K. Bovine adenovirus-3 as a vaccine delivery vehicle |
title | Bovine adenovirus-3 as a vaccine delivery vehicle |
title_full | Bovine adenovirus-3 as a vaccine delivery vehicle |
title_fullStr | Bovine adenovirus-3 as a vaccine delivery vehicle |
title_full_unstemmed | Bovine adenovirus-3 as a vaccine delivery vehicle |
title_short | Bovine adenovirus-3 as a vaccine delivery vehicle |
title_sort | bovine adenovirus-3 as a vaccine delivery vehicle |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115382/ https://www.ncbi.nlm.nih.gov/pubmed/25498212 http://dx.doi.org/10.1016/j.vaccine.2014.11.055 |
work_keys_str_mv | AT ayalewlisaneworke bovineadenovirus3asavaccinedeliveryvehicle AT kumarpankaj bovineadenovirus3asavaccinedeliveryvehicle AT gabaamit bovineadenovirus3asavaccinedeliveryvehicle AT makadiyaniraj bovineadenovirus3asavaccinedeliveryvehicle AT tikoosureshk bovineadenovirus3asavaccinedeliveryvehicle |